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Background: Abnormal lipid concentrations are risk factors for atherosclerosis and cardiovascular disease. The
pathological susceptibility to cardiovascular disease risks such as metabolic syndrome, diabetes mellitus,
hypertension, insulin resistance, and so on differs between Sasang constitutional types.
Methods: We used multiple regression analyses to study the association between lipid-related traits and genetic
variants from several genome-wide association studies according to Sasang constitutional types, considering that
the Tae-Eum (TE) has predominant cardiovascular risk.
Results: By analyzing 26 variants of 20 loci in two Korean populations (8,597 subjects), we found that 12 and 5
variants, respectively, were replicably associated with lipid levels and dyslipidemia risk. By analyzing TE and non-TE
type (each 2,664 subjects) populations classified on the basis of Sasang constitutional medicine, we found that the
minor allele effects of three variants enriched in TE type had a harmful influence on lipid risk (near apolipoprotein
A-V (APOA5)-APOA4-APOC3-APOA1 on increased triglyceride: p = 8.90 × 10−11, in APOE-APOC1-APOC4 on increased
low-density lipoprotein cholesterol: p = 1.63 × 10−5, and near endothelial lipase gene on decreased high-density
lipoprotein cholesterol: p = 4.28 × 10−3), whereas those of three variants (near angiopoietin-like 3 gene,
APOA5-APOA4-APOC3-APOA1, and near lipoprotein lipase gene on triglyceride and high-density lipoprotein
cholesterol) associated in non-TE type had neutral influences because of a compensating effect.
Conclusions: These results implied that the minor allele effects of lipid-associated variants may predispose TE
type subjects to high cardiovascular disease risk because of their genetic susceptibility to lipid-related disorders.
Keywords: Lipid-associated variants, Cholesterol, Dyslipidemia, ANGPTL3, APOA5-APOA4-APOC3-APOA1,
APOE-APOC1-APOC4, LIPG, LPL, Constitutional typeBackground
Dyslipidemia is characterized by abnormal levels of lipids,
including low-density lipoprotein cholesterol (LDLC),
high-density lipoprotein cholesterol (HDLC), and triglyce-
rides (TG), in the bloodstream. Although dyslipidemia is
not an apparent subjective symptom, it can be a major risk
factor for atherosclerosis and cardiovascular disease [1].
Sasang constitutional medicine classified human beings
into 4 groups on the basis of distinctive physical, physio-
logical, and psychological characteristics as constitutional* Correspondence: scha@kiom.re.kr
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reproduction in any medium, provided the ortypes [2]: Tae-Yang, So-Yang, Tae-Eum (TE), and So-Eum.
The TE type is associated with a square-shaped face, larger
waist circumference, and more sweating in comparison to
the other types [3-5]. The So-Eum type is inclined to a
slimmer body shape, lower appetite, and increased harm
avoidance [4,6-8]. The So-Yang type tends to more phy-
sical activity and novelty seeking [7,8]. No more than 0.1%
of the Korean population is composed of the Tae-Yang
type, which is slender-waisted and more charismatic,
although there have been too few population studies to
verify this type [9]. Because of the distinctive characteris-
tics mentioned above, the pathological susceptibility to
cardiometabolic disorders such as metabolic syndrome,
which includes an increased prevalence of dyslipidemia,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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also differs between TE and the other types [2,10-13].
Since the Sasang constitutional types are inheritable as re-
vealed by twin and family studies [2], elucidating how the
genetic variants can contribute to dyslipidemia suscepti-
bility between constitutional types is necessary, such as
several genetic variants associated with obesity- and lipid-
related traits of the TE type [14,15].
Several research groups have analyzed the results of
genome-wide association studies (GWAS) and replication
studies and reported several single nucleotide polymor-
phisms (SNPs) that affect blood lipid levels and are risk
factors for cardiovascular disease [16-19]. Common vari-
ants primarily associated with LDLC, HDLC, and TG
belong to the following loci: ABCG5, ABCG8, SORT1,
DNAH11, HMGCR, HNF1A, LDLR, MAFB, PCSK9, and
TIMD4-HAVCR1; ABCA1, ANGPTL4, CETP, GALN2,
HNF4A, LCAT, LIPG, MADD-FOLH1, MVK-MMAB, and
TTC39B; and ANGPTL3, GCKR, MLXIPL, TRIB1, and
XKR6-AMAC1L2, respectively. Moreover, some loci
associated with TG are simultaneously related to the loci
associated with HDLC (5 loci: APOA5-APOA4-APOC3-
APOA1, FADS1-FADS2-FADS3, LIPC, LPL, and PLTP) or
LDLC (3 loci: APOB, APOE-APOC clusters, and NCAN).
In this study, we identified SNPs associated with lipid-
related traits in TE and non-TE (NTE) type subjects.
We also analyzed the genetic risk for lipid disorders to
determine which constitutional types are more suscep-
tible to risk for cardiovascular disease.
Methods
Subjects
The 5,537 subjects (2,653 men and 2,884 women) were
recruited for a population-based cohort study, conduc-
ted as part of the Korean Genome and Epidemiology
Study (KoGES) for 4 years since 2009 [20], and the 3,060
subjects (1,123 men and 1,937 women) were recruited
from 22 oriental medical clinics who were a part of
the Korea Constitution Multicenter Study (KCMS) for
6 years since 2006. Of these subjects, 143 KoGES and
1,072 KCMS subjects had disease(s) such as hyperten-
sion, dyslipidemia, and/or diabetes. None of the subjects
from KoGES and KCMS populations had a history of
cancer treatment, thyroid dysfunctions, and postmeno-
pausal hormonal therapy. The recruited individuals were
analyzed using an integrated diagnostic model consisting
of face, body shape, voice, and questionnaire information
[21], namely the Sasang Constitutional Analysis Tool
(SCAT), in order to provide a basis for discriminating
Sasang constitutional types on the basis of probability
values for each constitutional type. On the basis of ter-
tiles of the SCAT probability values for the TE type, we
divided all subjects into 3 subgroups. We designated the
subjects on the top tertile as TE types (n = 1,824 in theKoGES; n = 840 in the KCMS), and the subjects on the
bottom tertile as NTE types (n = 1,824 in the KoGES;
n = 840 in the KCMS). All subjects provided written in-
formed consent to participate in the study, and the stu-
dies were approved by the Institutional Review Boards of
Korea Centers for Disease Control and Prevention (for
KoGES) and Korea Institute of Oriental Medicine (for
KCMS).
Selection and genotyping of SNPs
We selected 26 SNPs located in 20 genetic loci from 82
SNPs associated with lipid parameters reported in pre-
vious GWASs [16-19]. The 56 SNPs with the following
characteristics were excluded (1) 22 SNPs that had low
minor allele frequency (under 0.1), (2) 15 SNPs in tight
linkage disequilibrium (LD; r2 ≥ 0.7 in Asian HapMap
populations) via Haploview program (version 4.2) [22], (3)
4 SNPs that deviated from Hardy–Weinberg equilibrium
(p < 0.01) in the KoGES subjects, and (4) 15 SNPs
(containing the proxy SNPs: r2 ≥ 0.8 in Asian HapMap
populations) non-existent in the Affymetrix Genome-Wide
Human SNP array 5.0 (Affymetrix, Santa Clara, CA).
The genotypes of the 26 SNPs were determined using 2
genotyping methods by using Affymetrix SNP array 5.0
and unlabeled oligonucleotide probes (UOPs) on the given
polymorphic nucleotides [23]. The Affymetrix SNP array
5.0 was used in all KoGES subjects [20] and in 919 KCMS
subjects [24], and the UOP genotyping method was used
in 2,141 KCMS subjects. First, we screened the 15 repli-
cated SNPs in the KoGES population with 3 lipid parame-
ters such as LDLC, HDLC, and TG, in order to confirm
the association of GWAS SNPs with lipid parameters in
Koreans. Next, we performed genotyping of 15 SNPs in
KCMS subjects in order to double-check their associa-
tions with 3 lipid parameters in Koreans. The detailed
process of genotyping using UOPs for the 15 selected
SNPs (oligonucleotide sequences: see Additional file 1)
have been described in a previous report [25]. The geno-
types of the 14 SNPs except CETP rs9989419 (p < 0.01)
did not deviate from Hardy–Weinberg equilibrium in the
KCMS population. Therefore, we performed association
analyses using the 14 SNPs in the KCMS and combined
populations.
Statistical analysis
Chi-squared test was used to determine whether the
SNPs deviated from Hardy–Weinberg equilibrium in
each population. LD (Lewontin’s D′ = D/|Dmax| and r
2)
was obtained from Haploview program, version 4.2 (Daly
Lab at the Broad Institute, Cambridge, MA) [22].
Multiple linear regression analyses were performed for
LDLC, HDLC, and TG, after adjusting for age; sex; phy-
sical activity (3 categories); daily food intake (3 cate-
gories); and history and medications for hypertension,
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ciated with dyslipidemia risk (dyslipidemia according
to the National Cholesterol Education Program Adult
Treatment Panel III guidelines [26]: LDLC ≥ 160 mg/dL,
TG ≥ 200 mg/dL, total cholesterol ≥ 240 mg/dL, and/or
HDLC < 40 mg/dL (<50 mg/dL for women)) were deter-
mined using multiple logistic regression analyses with the
same adjustment used in the multiple linear regressions.
The p-values, after Bonferroni correction for multiple
comparisons, were considered significant in the combined
linear and logistic regression analyses; p-values of <0.05
were considered significant in each population analysis
(KoGES and KCMS). Combined analysis was performed
in a fixed effect model using Comprehensive Meta-
Analysis program, version 2.0 (Biostat, Englewood, NJ).
The other regression analyses were performed using R,
version 2.15.2 (http://www.r-project.org/).
Results
Characteristics of recruited subjects
The characteristics of the subjects from the KoGES and
KCMS populations are shown in Table 1. Since the aver-
age age and sex ratio between KoGES and KCMS sub-
jects were different, we combined the association results
for lipid parameters not by directly merging the 2 popu-
lations into one but by conducting meta-analyses of the
obtained associations in each population. The TE type
subjects presented relatively higher body mass index
(BMI), waist circumference, blood pressures, glucose
level, and lipid parameters such as LDLC, HDLC, and
TG, as well as cardiovascular risk factors such as dysli-
pidemia than those found in NTE type subjects; these
findings were consistent with those of previous reports
[4,10-13,27]. A majority of the subjects with TE type hadTable 1 Characteristics of recruited subjects
KoGES
Characteristic All (n = 5537) TE (n = 1824)
Age (y) 60.48 ± 8.54 61.32 ± 8.61
Female (%) 52.09 47.64
Body mass index (kg/m2) 24.46 ± 3.08 27.11 ± 2.58
Waist circumference (cm) 86.45 ± 8.39 93.28 ± 6.69
Total cholesterol (mg/dL) 193.25 ± 35.16 193.03 ± 34.90
LDL cholesterol (mg/dL) 119.96 ± 32.94 120.00 ± 33.35
HDL cholesterol (mg/dL) 45.85 ± 12.16 43.98 ± 10.79
Triglyceride (mg/dL) 143.28 ± 97.67 156.72 ± 102.30
Systolic blood pressure (mmHg) 119.97 ± 16.70 123.22 ± 15.85
Diastolic blood pressure (mmHg) 77.65 ± 10.25 79.48 ± 9.95
Fasting blood glucose (mg/dL) 101.26 ± 25.16 104.74 ± 27.10
Dyslipidemia (%) 62.96 69.96
Data are given as mean ± standard deviation or %.
Dyslipidemia: LDLC ≥ 160 mg/dL, TG ≥ 200 mg/dL, TC ≥ 240 mg/dL, and/or HDLC <BMI in the overweight range (BMI ≥ 25 kg/m2): 27.11
(±2.58) for the KoGES population and 26.35 (±2.83) for
the KCMS population (Table 1). Because high BMI along
with high waist circumference can pose a higher health
risk for diseases such as cardiometabolic disorders, in-
cluding lipid metabolism disorders, we measured the
blood lipid levels, including LDLC, HDLC, and TG, of
subjects of the TE type in order to estimate the genetic
effects of lipid-associated SNPs according to the consti-
tutional types.
Lipid-associated SNPs according to constitutional types
We reanalyzed the genome-wide associations of 26 SNPs
located in 20 gene loci selected from previous reports
[16-19] with lipid parameters, including LDLC, HDLC,
and TG, in the 2 populations. Of the 15 SNPs (SNP list:
see Additional file 1) showing associations with the lipid
parameters in the KoGES population, 12 in 10 gene loci
were selected from the analyses with a significance of
p < 0.00192 by Bonferroni correction (0.05 divided by 26
SNPs) in the combined population (Table 2). The asso-
ciation signals of 3 SNPs, rs10889353, rs2156552, and
rs17321515, were not significant in the KCMS population,
although the combined association signals were sig-
nificant. The lipid phenotypes associated with the 12 SNPs
well corresponded with the associations reported in the
previous papers [16-19]. The most significant SNP was
rs6589566 located near apolipoprotein A-V (APOA5) gene
and exerted an effect on TG levels in both populations
(KoGES, p < 2.0 × 10−16; KCMS, p = 7.25 × 10−12). Among
the SNPs that showed an overlap between lipid traits and
associated SNPs, rs4149270 (ATP-binding cassette trans-
porter A1 (ABCA1)), rs6589566 (APOA5), rs4420638
(apolipoprotein C-I (APOC1)), rs261332 (hepatic lipaseKCMS
NTE (n = 1824) All (n = 3060) TE (n = 840) NTE (n = 840)
59.53 ± 8.49 48.09 ± 15.69 52.48 ± 16.03 43.56 ± 14.88
56.36 63.30 53.93 73.70
21.94 ± 2.04 23.47 ± 3.33 26.35 ± 2.83 20.74 ± 2.26
79.76 ± 6.29 84.11 ± 9.88 92.47 ± 7.84 75.91 ± 6.94
193.90 ± 35.07 186.40 ± 35.33 191.32 ± 36.69 180.30 ± 33.14
120.16 ± 33.17 108.29 ± 30.93 113.92 ± 31.43 102.00 ± 28.87
47.98 ± 13.32 47.20 ± 12.32 43.30 ± 10.54 52.36 ± 12.65
133.36 ± 101.29 126.23 ± 82.59 153.45 ± 91.97 95.79 ± 57.79
116.57 ± 16.81 119.78 ± 15.68 125.44 ± 15.16 113.93 ± 15.00
75.61 ± 10.17 77.10 ± 11.26 80.55 ± 10.71 73.39 ± 11.09
97.75 ± 21.98 98.73 ± 28.24 106.26 ± 34.89 93.16 ± 17.89
59.65 57.06 70.36 40.60
40 mg/dL (<50 mg/dL for women).
Table 2 Linear regression analysis for lipid traits in the Korean population
Combined† KoGES KCMS
SNP (allele, gene) MAF Trait* n Effect (SE) [mg/dL] P-value‡ n Effect (SE) [mg/dL] P-value‡ n Effect (SE) [mg/dL] P-value‡
rs4149270 (C>T, ABCA1) 0.348 HDLC 8554 −0.956 (0.187) 3.10 × 10−7 5528 −0.806 (0.236) 6.51 × 10−4 3026 −1.205 (0.305) 7.93 × 10−5
rs10889353 (A>C, ANGPTL3) 0.173 TG 8575 −0.018 (0.004) 3.25 × 10−5 5536 −0.021 (0.005) 1.18 × 10−4 3039 −0.013 (0.007) 0.0739
rs1748195 (C>G, ANGPTL3) 0.221 TG 8582 −0.016 (0.004) 6.28 × 10−5 5536 −0.018 (0.005) 4.83 × 10−4 3046 −0.013 (0.007) 4.36 × 10−2
rs6589566 (A>G, APOA5) 0.217 TG 8569 0.044 (0.004) < 2.0 × 10−16 5528 0.043 (0.005) < 2.0 × 10−16 3041 0.046 (0.007) 7.25 × 10−12
HDLC 8569 −0.963 (0.220) 1.22 × 10−5 5528 −0.935 (0.278) 7.65 × 10−4 3041 −1.009 (0.361) 5.19 × 10−3
rs4420638 (T>C, APOC1) 0.115 LDLC 8579 4.103 (0.752) 4.87 × 10−8 5528 4.287 (0.951) 6.61 × 10−6 3051 3.796 (1.230) 2.04 × 10−3
TG 8579 0.018 (0.005) 4.80 × 10−4 5528 0.016 (0.0006) 1.47 × 10−2 3051 0.023 (0.009) 1.01 × 10−2
HDLC 8579 −1.108 (0.283) 8.87 × 10−5 5528 −0.983 (0.353) 5.41 × 10−3 3051 −1.329 (0.283) 4.80 × 10−3
rs174547 (T>C, FADS1) 0.330 TG 8575 0.014 (0.004) 6.25 × 10−5 5533 0.014 (0.004) 1.45 × 10−3 3042 0.014 (0.006) 1.54 × 10−2
rs3846663 (T>C, HMGCR) 0.473 LDLC 8587 −1.871 (0.477) 8.75 × 10−5 5537 −1.872 (0.611) 2.21 × 10−3 3050 −1.871 (0.763) 1.42 × 10−2
rs261332 (G>A, LIPC) 0.215 TG 8578 0.014 (0.004) 8.84 × 10−4 5528 0.012 (0.005) 1.51 × 10−2 3050 0.015 (0.007) 2.17 × 10−2
HDLC 8578 1.233 (0.219) 1.90 × 10−8 5528 1.124 (0.278) 5.36 × 10−5 3050 1.413 (0.357) 7.78 × 10−5
rs2156552 (A>T, LIPG) 0.164 HDLC 8583 −0.884 (0.242) 2.61 × 10−4 5536 −1.019 (0.309) 9.84 × 10−4 3047 −0.670 (0.390) 0.0858
rs1919484 (G>A, LPL) 0.208 TG 8577 −0.019 (0.004) 3.68 × 10−6 5535 −0.016 (0.005) 2.12 × 10−3 3042 −0.025 (0.007) 3.02 × 10−4
HDLC 8577 1.062 (0.220) 1.45 × 10−6 5535 0.733 (0.277) 8.04 × 10−3 3042 1.633 (0.365) 7.85 × 10−6
rs6586891 (C>A, LPL) 0.325 TG 8579 −0.016 (0.004) 5.56 × 10−6 5536 −0.015 (0.004) 7.91 × 10−4 3043 −0.018 (0.006) 2.04 × 10−3
HDLC 8579 1.096 (0.191) 9.39 × 10−9 5536 1.031 (0.242) 2.13 × 10−5 3043 1.203 (0.310) 1.07 × 10−4
rs17321515 (G>A, TRIB1) 0.439 TG 8573 0.013 (0.003) 1.59 × 10−4 5528 0.015 (0.0004) 3.19 × 10−4 3045 0.008 (0.006) 0.136
*Triglyceride (TG): log-transformed.
†Combined: combined meta-analysis of association signals in the KoGES and KCMS populations in a fixed effect model.
‡Superscript p-values indicate significant associations. Significance: p < 0.00192 (0.05/26 SNPs) in the combined population; p < 0.05 in the KoGES and KCMS populations.
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http://www.biomedcentral.com/1472-6882/14/230(LIPC)), rs2156552 (endothelial lipase (LIPG)), and 2 SNPs
of lipoprotein lipase (LPL), rs1919484 and rs6586891, were
found to be associated with HDLC (combined p-value:
3.10 × 10−7, 1.22 × 10−5, 8.87 × 10−5, 1.90 × 10−8, 2.61 ×
10−4, 1.45 × 10−6, and 9.39 × 10−9, respectively). For TG,
associations were found among rs10889353 and rs1748195
(angiopoietin-like 3 (ANGPTL3)), rs6589566 (APOA5),
rs4420638 (APOAC1), rs174547 (fatty acid desaturase 1
(FADS1)), rs261332 (LIPC), and rs1919484 and rs6586891
(LPL) (combined p-value: 3.25 × 10−5, 6.28 × 10−5, <2.0 ×
10−16, 4.80 × 10−4, 6.25 × 10−5, 8.84 × 10−4, 3.68 × 10−6,
and 5.56 × 10−6, respectively). Since the SNPs of the
ANGPTL3 and LPL genes were in strong LD within each
locus in the KCMS population (r2 = 0.72, D′ = 0.99 for
ANGPTL3 SNPs; r2 = 0.40, D′ = 0.87 for LPL SNPs), the
association patterns were similar between the 2 SNPs in
each locus. Therefore, we only focused on the effects of
rs10889353 for the ANGPTL3 allele and rs6586891 for the
LPL allele in the following analyses, which showed higher
significant signals in the combined analyses. For additional
LDLC, we selected rs4420638 and rs3846663 located near
APOC1 and 3-hydroxy-3-methylglutaryl-CoA-reductase
(HMGCR) gene loci, respectively (combined p-value:
4.87 × 10−8 and 8.75 × 10−5, respectively).
To determine genetic discrepancy for cardiovascular
risks between TE and NTE types, we extracted 2 sub-
groups, TE and NTE types, from all subjects, on the basis
of the tertiles of the SCAT probability values for TE con-
stitutional types [21]: TE type, in the top tertile, presented
a constitutional type with high cardiovascular risk, and
NTE type, in the bottom tertile, presented a constitutional
type with low cardiovascular risk. Of the 10 lipid-
associated SNPs of 10 loci in all population, 5 showed
significant and reproducible associations with lipid para-
meters in TE and/or NTE types (Table 3): the minor allele
effects of 3 SNPs (rs6589566 on TG, rs4420638 on LDLC,
and rs2156552 on HDLC) were enriched in TE type,
whereas those of 3 SNPs (rs10889353 on TG, rs6589566
on HDLC, and rs6586891 on HDLC) were enriched in
NTE type. The TG-increasing effect of rs6589566 was not
enriched in NTE type (the effect in NTE type was smaller
than that in all subjects), but remained significant.
In addition, by analyzing the associations of the 10 lipid-
associated SNPs with dyslipidemia risk, we found that 5
SNPs, rs4149270, rs6589566, rs4420638, rs261332, and
rs6586891, were significantly associated in the combined
population (p < 0.005; Bonferroni correction, 0.05/10 SNPs)
(combined p-value: 1.55 × 10−5 for rs4149270, 2.77 × 10−4
for rs6589566, 0.00218 for rs261332, and 4.31 × 10−6 for
rs6586891) (Table 4). The 3 SNPs, rs4149270, rs6589566,
and rs6586891, were repeatedly associated with dyslipi-
demia in both the populations, but the other 2 SNPs were
not significant in one of the 2 populations. After the
subgroup analysis, only rs261332 of the LIPC gene wassignificantly associated with dyslipidemia in the combined
NTE type, but the association was not reproduced in the
KCMS population (Table 4). In contrast, LPL rs6586891
was reproducibly associated in the NTE types of the
KoGES and KCMS populations, but was not significant in
the combined analysis of the NTE type.
Discussion
Analysis of the polymorphisms of gene loci associated with
lipid-related traits revealed significant associations of 12
SNPs out of the 26 selected GWAS SNPs; these SNPs were
located on ABCA1, ANGPTL3, APOA5-APOA4-APOC3-
APOA1, APOE-APOC1-APOC4, FADS1-FADS2-FADS3,
HMGCR, LIPC, LIPG, LPL, and TRIB1 gene regions. Inter-
estingly, minor alleles of the 3 SNPs of APOA5-APOA4-
APOC3-APOA1, APOE-APOC1-APOC4, and LIPG that
were enriched in TE type subjects exerted harmful influ-
ences on lipid risk, whereas the minor alleles of the SNPs
associated in NTE type subjects had both beneficial and
harmful, maybe neutral, influences on lipid risk (Table 3).
The rs6589566 near APOA5 significantly affected TG
levels in both TE and NTE types, which corresponded
with the previously reported association of rs662799
(strong LD with rs6589566: r2 = 0.59, D′ = 0.97 in the
KCMS population) with TG levels in TE type as well as in
So-Yang type subjects who partly belonged to the NTE
type [15]. For dyslipidemia risk, no significant reproducible
SNP associations were noted in the subgroup analysis for
the constitutional type. Taken together, the minor allele ef-
fects of lipid-associated SNPs appear to reflect the charac-
teristics of both the types (high in TE type and low in
other types) with regard to cardiovascular risk [2].
In the studied populations, most of the lipid-associated
loci such as ABCA1, APOA1, APOE, LIPC, and LPL were
known to be involved in lipoprotein metabolism [28].
Cholesterol is excreted from peripheral tissues such as in-
testine, liver, and macrophages, via the ABCA1 membrane
transporter to form HDL in association with the lipo-
protein, APOA1 [28]. LPL, which can be activated by
APOA5 and inhibited by ANGPTL3 [29,30], hydrolyzes
TG packaged into chylomicron and very low-density lipo-
protein, TG-rich lipoprotein particles, and LIPC is in-
volved in converting intermediate-density lipoproteins
formed from very low-density lipoproteins into LDL. In
addition, LIPG is also known to stimulate cholesteryl ester
uptake through hepatic scavenger receptor class B type I
[31], and APOC1 inhibits the action of cholesteryl ester
transfer protein [32] that is involved in transferring choles-
teryl ester from HDL to intermediate-density lipoproteins.
On the basis of this metabolism mechanism, we could
speculate the coordinated action of the lipid-associated
SNPs in each constitutional type. Since the minor allele ef-
fect of APOA5 rs6589566 was opposite to that of LPL
rs6586891 on the levels of TG and HDLC, the LPL activity
Table 3 Linear regression analysis for lipid traits in the subgroups of constitutional types
Combined† KoGES KCMS
SNP (allele, gene) Trait* Subject n Effect (SE) [mg/dL] P-value‡ n Effect (SE) [mg/dL] P-value‡ n Effect (SE) [mg/dL] P-value‡
rs4149270 HDLC TE 2646 −0.717 (0.301) 0.0171 1821 −0.728 (0.371) 4.97 × 10−2 825 −0.695 (0.514) 0.177
(C>T, ABCA1) NTE 2658 −1.144 (0.367) 1.82 × 10−3 1822 −1.173 (0.453) 9.60 × 10−3 836 −1.088 (0.627) 0.0802
rs10889353 TG TE 2656 −0.018 (0.008) 0.0233 1823 −0.020 (0.010) 4.35 × 10−2 833 −0.015 (0.014) 0.286
(A>C, ANGPTL3) NTE 2658 −0.023 (0.008) 2.33 × 10−3 1824 −0.022 (0.010) 2.35 × 10−2 834 −0.026 (0.013) 4.04 × 10−2
rs6589566 TG TE 2656 0.047 (0.007) 8.90 × 10−11 1820 0.047 (0.009) 2.09 × 10−7 836 0.049 (0.013) 1.22 × 10−4
(A>G, APOA5) NTE 2654 0.034 (0.007) 3.09 × 10−6 1823 0.030 (0.009) 1.04 × 10−3 831 0.042 (0.012) 6.99 × 10−4
HDLC TE 2656 −0.655 (0.350) 0.0615 1820 −0.698 (0.436) 0.110 836 −0.577 (0.589) 0.328
NTE 2654 −1.519 (0.440) 5.55 × 10−4 1823 −1.381 (0.539) 1.05 × 10−2 831 −1.795 (0.762) 1.87 × 10−2
rs4420638 LDLC TE 2659 6.028 (1.399) 1.63 × 10−5 1821 5.713 (1.731) 9.86 × 10−4 838 6.619 (2.373) 5.40 × 10−4
(T>C, APOC1) NTE 2654 2.789 (1.334) 0.0365 1820 3.027 (1.662) 0.0687 834 2.358 (2.236) 0.292
rs261332 HDLC TE 2658 1.026 (0.349) 3.29 × 10−3 1820 0.573 (0.436) 0.189 838 1.835 (0.583) 1.70 × 10−3
(G>A, LIPC) NTE 2655 1.931 (0.434) 8.51 × 10−6 1821 2.204 (0.529) 3.21 × 10−5 834 1.369 (0.758) 0.0713
rs2156552 HDLC TE 2660 −1.102 (0.386) 4.28 × 10−3 1823 −0.961 (0.477) 4.41 × 10−2 837 −1.370 (0.656) 3.72 × 10−2
(A>T, LIPG) NTE 2657 −1.049 (0.478) 0.0283 1824 −1.383 (0.596) 2.03 × 10−2 833 −0.441 (0.804) 0.583
rs6586891 TG TE 2661 −0.015 (0.006) 0.0229 1824 −0.012 (0.008) 0.131 837 −0.021 (0.011) 0.0685
(C>A, LPL) NTE 2656 −0.018 (0.006) 3.38 × 10−3 1824 −0.017 (0.008) 2.81 × 10−2 832 −0.020 (0.010) 0.0517
HDLC TE 2661 0.897 (0.309) 3.71 × 10−3 1824 0.718 (0.379) 0.0584 837 1.251 (0.534) 1.93 × 10−2
NTE 2656 1.404 (0.378) 2.00 × 10−4 1824 1.046 (0.472) 2.68 × 10−2 832 2.041 (0.629) 1.23 × 10−3
*Triglyceride (TG): log-transformed.
†Combined: combined meta-analysis of association signals in the KoGES and KCMS populations in a fixed effect model.
‡Superscript p-values indicate significant associations. Significance: p < 0.005 (0.05/10 SNPs) in the combined population; p < 0.05 in the KoGES and KCMS populations.

























Table 4 Logistic regression analysis for dyslipidemia risk
Combined* KoGES KCMS
n (MAF) n (MAF)
SNP (allele, gene) Subject OR (SE) P-value† Control Case OR (SE) P-value† Control Case OR (SE) P-value†
rs4149270 (C>T, ABCA1) All 1.157 (0.034) 1.55 × 10−5 2048 (0.330) 3480 (0.359) 1.136 (0.042) 2.49 × 10−3 1305 (0.275) 1728 (0.366) 1.194 (0.056) 1.55 × 10−3
TE 1.185 (0.064) 0.00826 594 (0.305) 1227 (0.350) 1.199 (0.077) 1.84 × 10−2 242 (0.349) 583 (0.387) 1.151 (0.115) 0.222
NTE 1.126 (0.060) 0.0491 755 (0.342) 1067 (0.364) 1.135 (0.073) 0.0816 499 (0.327) 337 (0.347) 1.106 (0.106) 0.344
rs6589566 (A>G, APOA5) All 1.156 (0.040) 2.77 × 10−4 2047 (0.203) 3481 (0.224) 1.150 (0.050) 5.13 × 10−3 1305 (0.203) 1735 (0.228) 1.167 (0.066) 1.99 × 10−2
TE 1.148 (0.075) 0.0648 593 (0.205) 1227 (0.222) 1.128 (0.090) 0.182 247 (0.206) 589 (0.235) 1.195 (0.134) 0.185
NTE 1.222 (0.072) 0.00536 755 (0.203) 1068 (0.224) 1.176 (0.087) 0.0628 493 (0.195) 338 (0.235) 1.328 (0.128) 2.68 × 10−2
rs4420638 (T>C, APOC1) All 1.232 (0.052) 5.53 × 10−5 2050 (0.100) 3478 (0.125) 1.286 (0.065) 9.52 × 10−5 1309 (0.107) 1742 (0.120) 1.140 (0.087) 0.132
TE 1.158 (0.100) 0.142 593 (0.094) 1227 (0.115) 1.266 (0.122) 0.0528 248 (0.113) 590 (0.114) 0.962 (0.176) 0.828
NTE 1.186 (0.091) 0.0614 755 (0.109) 1065 (0.131) 1.220 (0.109) 0.0677 495 (0.103) 339 (0.111) 1.110 (0.168) 0.535
rs261332(G>A, LIPC) All 0.883 (0.049) 2.18 × 10−3 2047 (0.226) 3481 (0.214) 0.918 (0.049) 0.0823 1308 (0.225) 1745 (0.198) 0.834 (0.065) 5.38 × 10−3
TE 0.901 (0.082) 0.177 591 (0.222) 1229 (0.216) 0.959 (0.089) 0.635 248 (0.242) 590 (0.204) 0.807 (0.128) 0.0934
NTE 0.818 (0.071) 4.68 × 10−3 755 (0.232) 1066 (0.201) 0.810 (0.085) 1.27 × 10−2 495 (0.211) 339 (0.187) 0.839 (0.129) 0.175
rs6586891 (C>A, LPL) All 0.854 (0.034) 4.31 × 10−6 2051 (0.343) 3485 (0.315) 0.859 (0.043) 4.37 × 10−4 1304 (0.345) 1739 (0.309) 0.846 (0.057) 3.10 × 10−3
TE 0.867 (0.065) 0.0275 594 (0.329) 1230 (0.316) 0.919 (0.078) 0.276 247 (0.360) 590 (0.302) 0.758 (0.118) 0.190
NTE 0.842 (0.062) 0.00555 755 (0.341) 1069 (0.313) 0.862 (0.076) 4.88 × 10−2 494 (0.333) 338 (0.288) 0.803 (0.108) 4.32 × 10−2
*Combined: combined meta-analysis of association signals in the KoGES and KCMS populations in a fixed effect model.
†Superscript p-values indicate significant associations. Significance: p < 0.005 (0.05/10 SNPs) in the combined population; p < 0.05 in the KoGES and KCMS populations.
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http://www.biomedcentral.com/1472-6882/14/230reducing the TG level [29] may be stimulated by the minor
allele of rs6586891 and inhibited by the minor allele of
rs6589566. In the NTE type (Table 3), the minor alleles of
rs4149270 near ABCA1 and rs6589566 near APOA1 may
reduce the HDLC level, and the reduced inhibitory effect
of the minor allele of ANGPTL3 rs10889353 on the LPL
activity may affect the reduction and increment in the
levels of TG and HDLC, respectively. On the other hand,
the reduced inhibitory effect of the C allele of APOC1
rs4420638 on the activity of cholesteryl ester transfer pro-
tein may increase the LDLC level in TE type, and the
HDLC-decreasing effect of LIPG rs2156552 minor allele
may be exerted because the hepatic uptake of cholesteryl
ester is affected (Table 3). Therefore, despite the unknown
mechanisms of lipid-associated SNPs, their effects might
reflect the relative pathological predisposition of each con-
stitutional type. Even though they are present in the non-
coding region and lack proper function, lipid-associated
SNPs might affect the expression of the genes harboring
them. Indeed, some groups have reported that lipid-asso-
ciated gene expression depends on distinct minor allelic
frequency in the human liver, strongly suggesting that
lipid-associated SNPs might influence gene expression as
the cis-acting regulator at the noncoding region [17].
The reason for the low frequency of lipid-associated
SNPs in the studied populations (12 SNPs from 26
SNPs) compared to that in Caucasians might be due to
the ethnic differences and small population size to detect
SNPs that have a minor role [16-19]. For example, the
minor allele frequencies (0.17, 0.12, 0.47, and 0.44, re-
spectively) of rs10889353, rs4420638, rs3846663, and
rs17321515 of 12 lipid-associated SNPs in Koreans were
different from those of the SNPs in Caucasians (0.32,
0.82, 0.62, and 0.56, respectively).
According to previous reports [4,10-13], TE type sub-
jects are susceptible to diverse metabolic diseases, in-
cluding obesity, diabetes, and hypertension, which are
well-known risk factors of cardiovascular diseases. In
addition, dyslipidemia that is characterized by the forma-
tion of atherosclerotic plaque in the bloodstream, an add-
itional risk for cardiovascular disease, is also prevalent in
TE type [10]. By analyzing the lipid-associated SNPs in the
TE and NTE type Koreans, we found that each constitu-
tional type has a distinct profile of SNPs associated with
lipid parameters, presenting a genetic predisposition to
vascular disease risk, especially in the TE type.
Conclusions
In conclusion, we found that 12 SNPs (in 10 gene loci)
of 26 SNPs (in 20 gene loci) were associated with the
genetic risk for lipid-related disorders. The constitution-
based genetic profiles for lipid levels were different bet-
ween TE and NTE types. That is, the TG-elevating
APOA5 minor allele, the LDLC-elevating APOC1 minorallele, and HDLC-decreasing LIPG minor allele were sig-
nificantly enriched in TE type, whereas minor alleles of
3 SNPs, ANGPTL3, APOA5, and LPL, compensated for
the effects on TG and HDLC. Therefore, our findings
suggest that TE type, unlike NTE type, may be at a
higher risk of cardiovascular diseases because of the
genetic risk for lipid-related disorders.
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